Β-CARYOPHYLLENE AS A PARTNER FOR DOXORUBICIN: EVIDENCE FOR CHEMOSENSITISATION, TISSUE PROTECTION AND LIPID-BASED CO-DELIVERY. FMHR [Internet]. 2026 Mar. 31 [cited 2026 Nov. 9];4(3):4636-45. Available from: https://fmhr.net/index.php/fmhr/article/view/3855